PEGS Boston reaches biologics teams earlier than the manufacturing shows do. Its audience is designing antibodies and proteins, not yet producing them, which makes it a strong fit for discovery-stage tools and services and a way to catch programs before a manufacturing decision is even on the table.
What PEGS Boston is
PEGS Boston is an annual protein and antibody engineering summit covering biologics discovery, engineering, and early development. Its audience is weighted toward discovery and early-development scientists working on antibodies, proteins, and other biologics, along with the reagent, assay, instrument, and services vendors that serve that work. Compared with the bioprocessing and manufacturing shows, PEGS sits earlier in a program's life.
The GTM signal at PEGS Boston
Exhibiting at PEGS reflects a budgeted decision to be visible to a discovery-stage biologics audience, the same strongest-signal logic that applies at any show. Because the audience is early-stage, presence here is a useful leading indicator: a program visible at PEGS may not reach a manufacturing or clinical decision for months or longer, which is exactly why building the relationship early matters. A named speaker tied to a specific engineering approach is a sharp contact-level hook. See selling around life science conferences for how to weigh the signals.
The outreach window
Exhibitor and speaker lists become public ahead of the May summit, giving a window to cross-reference the roster against your biologics account list and plan specific outreach before the doors open. Because the audience is discovery-stage, outreach that speaks to a specific engineering or early-development need lands better than a manufacturing-scale pitch. On-site outreach works as a fallback, and the post-show window holds for a few weeks while a reference to a specific conversation is still fresh.
Who this matters most for
A tools or services vendor selling reagents, assays, instruments, or services into biologics discovery and engineering should treat PEGS Boston as a primary show. A CRO offering discovery or early-development biologics services will find a close-fit audience. A CDMO can use PEGS to identify biologics programs early and build the relationship ahead of a later manufacturing need.